KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Operating Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 2,500.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -91.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 395.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4,555.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -53.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1,031.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -9,003.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -338.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -53.00
Dec 31, 2025 -45,827.00
Sep 30, 2025 -1,356.00
Jun 30, 2025 -406.00
Mar 31, 2025 -2,562.00
Dec 31, 2024 -822.00
Sep 30, 2024 -1,139.00
Jun 30, 2024 1,007.00
Mar 31, 2024 -2,277.00
Dec 31, 2023 -1,619.00
Sep 30, 2023 -891.00
Jun 30, 2023 99.00
Mar 31, 2023 -676.00
Dec 31, 2022 45,101.00
Sep 30, 2022 -534.00
Jun 30, 2022 -1,504.00
Mar 31, 2022 -669.00
Dec 31, 2021 -604.00
Sep 30, 2021 -670.00
Jun 30, 2021 -3,718.00
Mar 31, 2021 -1,494.00
Dec 31, 2020 -861.00
Sep 30, 2020 -654.00
Jun 30, 2020 -1,097.00
Mar 31, 2020 -1,161.00
Dec 31, 2019 -906.00
Sep 30, 2019 -49.00
Jun 30, 2019 457.00
Mar 31, 2019 92.00
Dec 31, 2018 154.00
Sep 30, 2018 -24.00
Jun 30, 2018 1,014.00
Mar 31, 2018 953.00
Dec 31, 2017 1,211.00
Sep 30, 2017 1,449.00
Jun 30, 2017 997.00
Mar 31, 2017 1,852.00
Dec 31, 2016 1,915.00
Sep 30, 2016 949.00
Jun 30, 2016 975.00
Mar 31, 2016 1,111.00
Dec 31, 2015 1,306.00
Sep 30, 2015 853.00
Jun 30, 2015 190.00
Mar 31, 2015 362.00
Dec 31, 2014 -154.00
Sep 30, 2014 1,670.00
Jun 30, 2014 422.00
Mar 31, 2014 -442.00
Dec 31, 2013 -367.00
Sep 30, 2013 -302.00
Jun 30, 2013 -825.00
Mar 31, 2013 -724.00
Dec 31, 2012 -492.00
Sep 30, 2012 -909.00
Jun 30, 2012 -226.00
Mar 31, 2012 -293.00